These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
428 related items for PubMed ID: 19157636
21. Angiogenic molecule expression is downregulated in effusions from breast cancer patients. Konstantinovsky S, Nielsen S, Vyberg M, Kvalheim G, Nesland JM, Reich R, Davidson B. Breast Cancer Res Treat; 2005 Nov; 94(1):71-80. PubMed ID: 16142438 [Abstract] [Full Text] [Related]
22. Vinorelbine is effective for the malignant pleural effusion associated with lung cancer in mice. Cui R, Yoshioka M, Takahashi F, Ishida H, Iwakami S, Takahashi K. Anticancer Res; 2008 Nov; 28(3A):1633-9. PubMed ID: 18630520 [Abstract] [Full Text] [Related]
23. [Plasma level and prognostic significance of VEGF, bFGF and MMP-9 in patients with advanced non-small-cell lung cancer]. Zhao J, Liu XY, Zhang QY, Jiang W. Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):676-9. PubMed ID: 16438890 [Abstract] [Full Text] [Related]
25. Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Tanaka F, Ishikawa S, Yanagihara K, Miyahara R, Kawano Y, Li M, Otake Y, Wada H. Cancer Res; 2002 Dec 01; 62(23):7124-9. PubMed ID: 12460935 [Abstract] [Full Text] [Related]
27. Prognostic value of pleural effusion in patients with non-small cell lung cancer. Sugiura S, Ando Y, Minami H, Ando M, Sakai S, Shimokata K. Clin Cancer Res; 1997 Jan 01; 3(1):47-50. PubMed ID: 9815536 [Abstract] [Full Text] [Related]
33. Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer. Chen F, Takenaka K, Ogawa E, Yanagihara K, Otake Y, Wada H, Tanaka F. Clin Cancer Res; 2004 Dec 15; 10(24):8548-53. PubMed ID: 15623638 [Abstract] [Full Text] [Related]
34. Serum angiopoietin-1 as a prognostic marker in resected early stage lung cancer. Park JH, Choi H, Kim YB, Kim YS, Sheen SS, Choi JH, Lee HL, Lee KS, Chung WY, Lee S, Park KJ, Hwang SC, Lee KB, Park KJ. Lung Cancer; 2009 Dec 15; 66(3):359-64. PubMed ID: 19339077 [Abstract] [Full Text] [Related]
35. Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancer. Ishiwata T, Takahashi K, Shimanuki Y, Ohashi R, Cui R, Takahashi F, Shimizu K, Miura K, Fukuchi Y. Anticancer Res; 2005 Dec 15; 25(1B):489-95. PubMed ID: 15816617 [Abstract] [Full Text] [Related]
37. The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients. Kadota K, Huang CL, Liu D, Ueno M, Kushida Y, Haba R, Yokomise H. Eur J Cancer; 2008 May 15; 44(7):1057-67. PubMed ID: 18396396 [Abstract] [Full Text] [Related]
39. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion. Du N, Li X, Li F, Zhao H, Fan Z, Ma J, Fu Y, Kang H. Oncol Rep; 2013 Jun 15; 29(6):2332-40. PubMed ID: 23525453 [Abstract] [Full Text] [Related]